EASL Education

⏬Download the Best of #EASLCongress Slide Decks on #EASLCampus! These editable Slide Decks bring together the top selected abstracts from the Congress in each topic track. 📚 🔗easlcampus.eu/Documents/best… @EASLNews @CornbergMarkus @JasmohanBajaj @hlcortezpinto @Alexfornergon @horstef @SilviaAffo #LiverX #BestOf

Join EASL-@ESP_Pathology course and earn up to 5.5 CME credits!🤩 Discover the 7⃣modules exploring key aspects of biopsy use, from its changing indications to its role in diagnosing conditions such as MASLD, autoimmune hepatitis, and hereditary liver diseases. 📍easlcampus.eu/course/easl-esp @EASLnews #LiverX #PathX

📢The July issue has been released❗️ 👉Check out the complete edition 👇 jhep-reports.eu/current #LiverTwitter #LiverX @EASLedu @EASLnews

🔥New episode of #TalkLivertoMe now available! In this episode, experts explore liver–heart crosstalk, shared cardiometabolic risk, and why closer collaboration between hepatology and cardiology matters. 🎙️Spotify: open.spotify.com/episode/6yi2O3… 🎙️Apple Podcasts: podcasts.apple.com/us/podcast/tal… 📺EASL Campus: easlcampus.eu/tltm/episode-12 @tom_marjot @DebbieShawcros1 @escardio #LiverX #MASLD #HPfEF

OS in EMERALD-1: A phase III study of durvalumab ± beva and TACE in unresectable embolisation-eligible HCC 👉OR & PFS improved 👉no OS benefit 🧐No safety concerns, but also not strongly supporting the combination @myESMO @EASLedu @ILCAnews

🔥off the press🔥 Systemic therapy for HCC: Doublets, triplets and beyond @JHepatology 👉comprehensive summary of systemic therapies in HCC 👇my author link authors.elsevier.com/sd/article/S01… @myESMO @EASLedu @ilca

They say great ideas happen when people come together. 🤝 That's why the EASL Educational Committee is currently in Antwerp building the next chapter of our educational programmes, ensuring that what we build today will support our network for years to come! Plenty of ideas in the works, so stay tuned... ✨ @EASLnews

The #EASLSchool of Hepatology on Artificial Intelligence in Hepatology took place last week in Dresden, Germany 🇩🇪 Students dove deep into AI literacy, gaining hands-on skills in machine learning, deep learning, and image processing to build and critically evaluate AI applications in liver disease. 🤖🔬 @jnkath @C_V_Schneider @JClusmann @GhaffariNarmin #LiverX

⭐️Listen to the latest Talk Liver To Me episode! Does the perfect preclinical model exist? In this episode, we explore the new EASL position paper on preclinical models of steatotic liver disease with Rui Castro, Mathias Heikenwälder and Suchira Gallage. Together, they discuss the challenges of modelling MASLD, MetALD, and ALD, and what researchers and clinicians should know when interpreting preclinical data. 👉Available on EASL Campus: easl.eu/event/chasing-… 🎙️Spotify: open.spotify.com/episode/524b5Q… 🎙️Apple Podcast: podcasts.apple.com/us/podcast/tal… @RuiCastroHD @CancerInflam @GallageSuchira @EASLedu

Very proud to have written this EASL postion paper togehter with so many fantastic people - as well as to have done this #talklivertoME episode with Rui and Suchira - always a pleasure.

New episode of #TalkLivertoMe is now available! 🎙️ 🐁Mice, organoids, precision-cut liver slices, human-based systems… which models best reflect human #SLD? Or maybe the better question is: Which model is best for the endpoint you’re investigating?🤔 Read the position papar and listen below. 📰journal-of-hepatology.eu/article/S0168-… 📺easlcampus.eu/tltm/episode-11 🎙️open.spotify.com/episode/524b5Q… 🎙️podcasts.apple.com/us/podcast/tal… @JHepatology #LiverX

🏫The #EASLSchool of Hepatology on #PSC is underway in Hamburg, Germany 🇩🇪 Students are joining leading experts to explore the latest insights in primary sclerosimg cholangitis, tackle complex clinical decisions, and connect with peers from across the hepatology community. @EASLnews @LohseAnsgar #LiverX

@tom_marjot @EASLedu @EASLnews @JHepatology @DebbieShawcros1 @analleo @IronOverloadUK @ironoverloadUS @MattiasMandorf1 @basl_events Delighted to contribute to this really enjoyable podcast during Haemochromatosis awareness week!! @IrelandLiver @IrishHaemAssoc For more iron research and clinical practice come to EIC2026 in Trinity College Dublin next week!! eic-2026.com

🎧 New EASL #TalkLiverToMe podcast Haemochromatosis: Who Needs Testing & Who Needs Treatment? We discuss: 🩸 Iron profiles 🩸 Genotypes 🩸 Penetrance 🩸 Fibrosis staging 🩸 Ferritin targets 🩸 Arthropathy 🎧 Apple: apple.co/4unlnfJ 🎧 Spotify: bit.ly/43ZAhy4

For #HaemochromatosisAwarenessWeek, we’re spotlighting one of the most common inherited metabolic disorders, still too often underdiagnosed and inconsistently managed. Join @tom_marjot as he talks to John Ryan and Heinz Zoller, panellists on the 2022 EASL CPG on haemochromatosis, to explore diagnosis, testing, and modern management. 📰journal-of-hepatology.eu/article/S0168-… 💻easlcampus.eu/tltm/episode-10 🎙️podcasts.apple.com/us/podcast/tal… 🎙️open.spotify.com/episode/13aAqb… @JHepatology @IronOverloadUK @IrishHaemAssoc #TalkLivertoMe #Haemochromatosis

🔟 Adios Barcelona, Hello London Join us as we look back at the highlights of #EASLCongress 2026 and look ahead to the road to London and the future of hepatology. ▶️ Watch on demand: easlcampus.eu/webcast/easl-s… #EASLStudio

9️⃣ Landmark studies at EASL Congress 2026 Catch up on some of the most important studies presented at #EASLCongress 2026 and hear expert perspectives on their implications for research and clinical practice. ▶️ Watch on demand: easlcampus.eu/webcast/easl-s… #EASLStudio

Missed #EASLStudio at #EASLCongress 2026? 🎙️ Catch up on all 10 episodes, from MASH cirrhosis and HBV cure strategies to PBC care, landmark studies, liver policy, and the future of hepatology. ▶️ easlcampus.eu/search/resourc… Discover them below 👇